Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,906,603
+$6,870,228 QoQ
Shares Held
428,400
+33.8% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 240 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Sep 30, 2021CallValue
$43,104
CallShares
160
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. NKTR ranks #53 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in NKTR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,906,603 | 428,400 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $23,036,375 | 320,172 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $12,158,077 | 287,561 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,167,770 | 90,822 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,203,425 | 201,371 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $222,570 | 327,310 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $284,513 | 305,929 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,275 | 112,521 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $71,315 | 57,513 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,970 | 3,194 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $137,725 | 245,940 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $29,337 | 48,897 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,716 | 9,856 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,704 | 11,007 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,779 | 11,407 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $47,465 | 14,833 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $47,260 | 12,437 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $100,393 | 18,626 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $266,660 | 19,738 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $43,104 | 2,400 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $562,182 | 31,302 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,466,217 | 143,719 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,756,480 | 87,824 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,098,922 | 123,466 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,039,806 | 122,954 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $658,021 | 28,412 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,503,879 | 84,251 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||